1,266
Views
0
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Audiological ototoxicity monitoring guidelines: a review of current evidence and appraisal of quality using the AGREE II tool

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 31 Mar 2023, Accepted 27 Oct 2023, Published online: 07 Dec 2023

References

  • Agree Collaboration. 2009. “Appraisal of Guidelines for Research and Evaluation in Europe ǁ (AGREE ǁ) Instrument.” Accessed May 12, 2019. http://www.agreetrust.org/
  • American Academy of Audiology. 2009. “Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring.” https://audiology-web.s3.amazonaws.com/migrated/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf
  • American Speech-Language Hearing Association. 1994. “Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy.” https://www.asha.org/policy/gl1994-00003/
  • Bargeri, S., V. Iannicelli, G. Castellini, M. Cinquini, and S. Gianola. 2021. “AGREE II Appraisals of Clinical Practice Guidelines in Rehabilitation Showed Poor Reporting and Moderate Variability in Quality Ratings When Users Apply Different Cuff-Offs: A Methodological Study.” Journal of Clinical Epidemiology 139:222–231. https://doi.org/10.1016/j.jclinepi.2021.08.021
  • Bigelow, R. T., N. S. Reed, K. K. Brewster, A. Huang, G. Rebok, B. R. Rutherford, and F. R. Lin. 2020. “Association of Hearing Loss With Psychological Distress and Utilization of Mental Health Services Among Adults in the United States.” JAMA Network Open 3 (7):e2010986. https://doi.org/10.1001/jamanetworkopen.2020.10986
  • Brouwers, M. C., K. Kerkvliet, and K. Spithoff. 2016. “The AGREE Reporting Checklist: A Tool to Improve Reporting of Clinical Practice Guidelines.” BMJ (Clinical Research ed.) 352:i1152. https://doi.org/10.1136/bmj.i1152
  • Brouwers, M. C., M. E. Kho, G. P. Browman, J. S. Burgers, F. Cluzeau, G. Feder, B. Fervers, I. D. Graham, J. Grimshaw, S. E. Hanna, et al. 2010c. “AGREE II: Advancing Guideline Development, Reporting and Evaluation in Health Care.” CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne 182 (18):E839–E842. https://doi.org/10.1503/cmaj.090449
  • Brouwers, M. C., M. E. Kho, G. P. Browman, J. S. Burgers, F. Cluzeau, G. Feder, B. Fervers, I. D. Graham, S. E. Hanna, and J. Makarski. 2010a. “Development of the AGREE II, Part 1: Performance, Usefulness and Areas for Improvement.” CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne 182 (10):1045–1052. https://doi.org/10.1503/cmaj.091714
  • Brouwers, M. C., M. E. Kho, G. P. Browman, J. S. Burgers, F. Cluzeau, G. Feder, B. Fervers, I. D. Graham, S. E. Hanna, and J. Makarski. 2010b. “Development of the AGREE II, Part 2: Assessment of Validity of Items and Tools to Support Application.” CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne 182 (10):E472–E478. https://doi.org/10.1503/cmaj.091716
  • Castiglione, A., A. Benatti, C. Velardita, D. Favaro, E. Padoan, D. Severi, M. Pagliaro, R. Bovo, A. Vallesi, C. Gabelli, et al. 2016. “Aging, Cognitive Decline and Hearing Loss: Effects of Auditory Rehabilitation and Training with Hearing Aids and Cochlear Implants on Cognitive Function and Depression among Older Adults.” Audiology & Neuro-Otology 21 Suppl 1:21–28. https://doi.org/10.1159/000448350
  • Cazals, Y. 2000. “Auditory Sensori-Neural Alterations Induced by Salicylate.” Progress in Neurobiology 62 (6):583–631. https://doi.org/10.1016/s0301-0082(00)00027-7
  • Dillard, L. K., L. Lopez-Perez, R. X. Martinez, A. M. Fullerton, S. Chadha, and C. M. McMahon. 2022. “Global Burden of Ototoxic Hearing Loss Associated with Platinum-Based Cancer Treatment: A Systematic Review and Meta-Analysis.” Cancer Epidemiology 79:102203. https://doi.org/10.1016/j.canep.2022.102203
  • Dille, M. F., P. G. Jacobs, S. Y. Gordon, W. J. Helt, and G. P. McMillan. 2013. “OtoID: New Extended Frequency, Portable Audiometer for Ototoxicity Monitoring.” Journal of Rehabilitation Research and Development 50 (7):997–1006. https://doi.org/10.1682/JRRD.2012.09.0176
  • Dille, M. 2018. “Barriers and Potential Solutions to Increase the Success of Ototoxicity Monitoring.” American Speech-Language Hearing Association. https://www.asha.org/articles/barriers-and-potential-solutions-to-increase-the-success-of-ototoxicity-monitoring-programs/
  • Ehlert, K., B. Heinze, and D. W. Swanepoel. 2022. “Ototoxicity Monitoring in South African Cancer Facilities: A National Survey.” The South African Journal of Communication Disorders = Die Suid-Afrikaanse Tydskrif Vir Kommunikasieafwykings 69 (1):e1–e10. https://doi.org/10.4102/sajcd.v69i1.846
  • Eikermann, M., N. Holzmann, U. Siering, and A. Rüther. 2014. “Tools for Assessing the Content of Guidelines Are Needed to Enable Their Effective Use–A Systematic Comparison.” BMC Research Notes 7 (1):853. https://doi.org/10.1186/1756-0500-7-853
  • Fausti, S. A., M. A. Schechter, B. Z. Rappaport, R. H. Frey, and R. E. Mass. 1984. “Early Detection of Cisplatin Ototoxicity Selected Case Reports.” Cancer 53 (2):224–231. https://doi.org/10.1002/1097-0142(19840115)53:2<224::AID-CNCR2820530207>3.0.CO;2-D.
  • Fu, X., P. Wan, P. Li, J. Wang, S. Guo, Y. Zhang, Y. An, C. Ye, Z. Liu, J. Gao, et al. 2021. “Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides.” Frontiers in Cellular Neuroscience 15:692762. https://doi.org/10.3389/fncel.2021.692762 PMID: 34211374; PMCID: PMC8239227.
  • Ganesan, P., J. Schmiedge, V. Manchaiah, S. Swapna, S. Dhandayutham, and P. P. Kothandaraman. 2018. “Ototoxicity: A Challenge in Diagnosis and Treatment.” Journal of Audiology & Otology 22 (2):59–68. https://doi.org/10.7874/jao.2017.00360
  • Garinis, A. C., C. P. Cross, P. Srikanth, K. Carroll, M. P. Feeney, D. H. Keefe, L. L. Hunter, D. B. Putterman, D. M. Cohen, J. A. Gold, et al. 2017. “The Cumulative Effects of Intravenous Antibiotic Treatments on Hearing in Patients with Cystic Fibrosis.” Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 16 (3):401–409. https://doi.org/10.1016/j.jcf.2017.01.006
  • Guo, L., W. Cao, Y. Niu, S. He, R. Chai, and J. Yang. 2021. “Autophagy Regulates the Survival of Hair Cells and Spiral Ganglion Neurons in Cases of Noise, Ototoxic Drug, and Age-Induced Sensorineural Hearing Loss [Review.” Frontiers in Cellular Neuroscience 15:760422. https://doi.org/10.3389/fncel.2021.760422
  • Guyatt, G., and P. O. Vandvik. 2013. “Creating Clinical Practice Guidelines: Problems and Solutions.” Chest 144 (2):365–367. https://doi.org/10.1378/chest.13-0463
  • Hakkennes, S., and K. Dodd. 2008. “Guideline Implementation in Allied Health Professions: A Systematic Review of the Literature.” Quality & Safety in Health Care 17 (4):296–300. https://doi.org/10.1136/qshc.2007.023804
  • Health Professionals Council of South Africa. 2018. “Guidelines for the Audiological Management of Patients on Treatment That Includes Ototoxic Medications.” https://www.hpcsa.co.za/Uploads/SLH/Guidelines%20for%20Audiological%20Management%20of%20Patients%20on%20Treatment%20that%20includes%20Ototoxic%20Medications.pdf
  • Heine, C., and C. Browning. 2004. “The Communication and Psychosocial Perceptions of Older Adults with Sensory Loss: A Qualitative Study.” Ageing and Society 24 (1):113–130. https://doi.org/10.1017/S0144686X03001491
  • Hollander, C., K. Joubert, and N. Schellack. 2020. “An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.” JMIR mHealth and uHealth 8 (1):e14036. https://doi.org/10.2196/14036
  • Jayakody, D. M. P., O. P. Almeida, C. P. Speelman, R. J. Bennett, T. C. Moyle, J. M. Yiannos, and P. L. Friedland. 2018. “Association between Speech and High-Frequency Hearing Loss and Depression, Anxiety and Stress in Older Adults.” Maturitas 110:86–91. https://doi.org/10.1016/j.maturitas.2018.02.002
  • Jung, T. T., C. K. Rhee, C. S. Lee, Y. S. Park, and D. C. Choi. 1993. “Ototoxicity of Salicylate, Nonsteroidal Antiinflammatory Drugs, and Quinine.” Otolaryngologic Clinics of North America 26 (5):791–810. https://doi.org/10.1016/S0030-6665(20)30767-2
  • Khoza-Shangase, K. 2017. “Risk Versus Benefit: Who Assesses This in the Management of Patients on Ototoxic Drugs?” Journal of Pharmacy & Bioallied Sciences 9 (3):171–177. https://doi.org/10.4103/jpbs.JPBS_17_17
  • Khoza-Shangase, K., and N. Masondo. 2021. “In Pursuit of Preventive Audiology in South Africa: Scoping the Context for Ototoxicity Assessment and Management.” Journal of Pharmacy & Bioallied Sciences 13 (1):46–60. https://doi.org/10.4103/jpbs.JPBS_334_19
  • Konrad-Martin, D., R. Polaski, J. R. Debacker, S. M. Theodoroff, A. Garinis, C. Lacey, K. Johansson, R. Mannino, T. Milnes, M. Hungerford, et al. 2023. “Audiologists’ Perceived Value of Ototoxicity Management and Barriers to Implementation for At-Risk Cancer Patients in VA: The OtoMIC Survey.” Journal of Cancer Survivorship: Research and Practice 17 (1):69–81. https://doi.org/10.1007/s11764-022-01316-7
  • Konrad-Martin, D., G. L. Poling, A. C. Garinis, C. E. Ortiz, J. Hopper, K. O'Connell Bennett, and M. F. Dille. 2018. “Applying U.S. National Guidelines for Ototoxicity Monitoring in Adult Patients: Perspectives on Patient Populations, Service Gaps, Barriers and Solutions.” International Journal of Audiology 57 (sup4):S3–S18. https://doi.org/10.1080/14992027.2017.1398421
  • Kovacic, P., and R. Somanathan. 2008. “Ototoxicity and Noise Trauma: Electron Transfer, Reactive Oxygen Species, Cell Signaling, Electrical Effects, and Protection by Antioxidants: Practical Medical Aspects.” Medical Hypotheses 70 (5):914–923. https://doi.org/10.1016/j.mehy.2007.06.045
  • Kros, C. J., and P. S. Steyger. 2019. “Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.” Cold Spring Harbor Perspectives in Medicine 9 (11):a033548. https://doi.org/10.1101/cshperspect.a033548
  • Livingston, G., A. Sommerlad, V. Orgeta, S. G. Costafreda, J. Huntley, D. Ames, C. Ballard, S. Banerjee, A. Burns, J. Cohen-Mansfield, et al. 2017. “Dementia Prevention, Intervention, and Care.” Lancet (London, England) 390 (10113):2673–2734. https://doi.org/10.1016/S0140-6736(17)31363-6
  • Loughrey, D. G., M. E. Kelly, G. A. Kelley, S. Brennan, and B. A. Lawlor. 2018. “Association of Age-Related Hearing Loss with Cognitive Function, Cognitive Impairment, and Dementia: A Systematic Review and Meta-Analysis.” JAMA Otolaryngology- Head & Neck Surgery 144 (2):115–126. https://doi.org/10.1001/jamaoto.2017.2513
  • Maru, D., and G. A. Malky. 2018. “Current Practice of Ototoxicity Management across the United Kingdom (UK).” International Journal of Audiology 57 (sup4):S76–S88. https://doi.org/10.1080/14992027.2018.1460495
  • Medves, J., C. Godfrey, C. Turner, M. Paterson, M. Harrison, L. MacKenzie, and P. Durando. 2010. “Systematic Review of Practice Guideline Dissemination and Implementation Strategies for Healthcare Teams and Team‐Based Practice.” International Journal of Evidence-Based Healthcare 8 (2):79–89. https://doi.org/10.1111/j.1744-1609.2010.00166.x
  • Patel, K., L. Thibodeau, D. McCullough, E. Freeman, and I. Panahi. 2021. “Development and Pilot Testing of Smartphone-Based Hearing Test Application.” International Journal of Environmental Research and Public Health 18 (11):5529. https://doi.org/10.3390/ijerph18115529
  • Pearson, S. E., C. Caimino, M. Shabbir, and D. M. Baguley. 2022. “The Impact of Chemotherapy-Induced Inner Ear Damage on Quality of Life in Cancer Survivors: A Qualitative Study.” Journal of Cancer Survivorship: Research and Practice 16 (5):976–987. https://doi.org/10.1007/s11764-021-01089-5
  • Peer, S., and J. J. Fagan. 2015. “Hearing Loss in the Developing World: Evaluating the iPhone Mobile Device as a Screening Tool.” South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde 105 (1):35–39. https://doi.org/10.7196/samj.8338
  • Pichora-Fuller, M. K., and G. Singh. 2006. “Effects of Age on Auditory and Cognitive Processing: Implications for Hearing Aid Fitting and Audiologic Rehabilitation.” Trends in Amplification 10 (1):29–59. https://doi.org/10.1177/108471380601000103
  • Pickles, J. 1982. An introduction to the physiology of hearing: Fourth edition. Bingley, UK: Emerald Group Publishing Limited
  • Rybak, L. P., and V. Ramkumar. 2007. “Ototoxicity.” Kidney International 72 (8):931–935. https://doi.org/10.1038/sj.ki.5002434
  • Santucci, N. M., B. Garber, R. Ivory, M. A. Kuhn, M. Stephen, and D. Aizenberg. 2021. “Insight into the Current Practice of Ototoxicity Monitoring during Cisplatin Therapy.” Journal of Otolaryngology - Head & Neck Surgery 50 (1):19. https://doi.org/10.1186/s40463-021-00506-0
  • Shinn-Cunningham, B. G., and V. Best. 2008. “Selective Attention in Normal and Impaired Hearing.” Trends in Amplification 12 (4):283–299. https://doi.org/10.1177/1084713808325306
  • Siering, U., M. Eikermann, E. Hausner, W. Hoffmann-Eßer, and E. A. Neugebauer. 2013. “Appraisal Tools for Clinical Practice Guidelines: A Systematic Review.” PloS One 8 (12):e82915. https://doi.org/10.1371/journal.pone.0082915
  • Steffens, L., K. Venter, G. A. O'Beirne, R. Kelly-Campbell, D. Gibbs, and P. Bird. 2014. “The Current State of Ototoxicity Monitoring in New Zealand.” The New Zealand Medical Journal 127 (1398):84–97.
  • Steyger, P. S. 2011. “Mechanisms Involved in Ototoxicity.” Seminars in Hearing 32 (3):217–228. https://doi.org/10.1055/s-0031-1286616
  • Wahl, H. W., V. Heyl, P. M. Drapaniotis, K. Hörmann, J. B. Jonas, P. K. Plinkert, and K. Rohrschneider. 2013. “Severe Vision and Hearing Impairment and Successful Aging: A Multidimensional View.” The Gerontologist 53 (6):950–962. https://doi.org/10.1093/geront/gnt013
  • World Health Organisaiton. 2017. Global Cost of Unaddressed Hearing Loss and Cost-Effectiveness of Interventions: A WHO Report. https://apps.who.int/iris/handle/10665/254659
  • World Health Organisation. 2021. World Report on Hearing. https://www.who.int/teams/noncommunicable-diseases/sensory-functions-disability-and-rehabilitation/highlighting-priorities-for-ear-and-hearing-care